C17orf113
gene geneOn this page
Summary
C17orf113 (chromosome 17 open reading frame 113, HGNC:53437) is a protein-coding gene on chromosome 17q21.2, encoding Uncharacterized protein C17orf113 (A0A1B0GUU1).
At a glance
- MANE Select transcript:
NM_001358661
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53437 |
| Approved symbol | C17orf113 |
| Name | chromosome 17 open reading frame 113 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000267221 |
| Ensembl biotype | protein_coding |
| Entrez | 110806298 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000587304, ENST00000858984
RefSeq mRNA: 1 — MANE Select: NM_001358661
NM_001358661
CCDS: CCDS86598
Canonical transcript exons
ENST00000587304 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002740429 | 42042834 | 42043563 |
| ENSE00002796523 | 42038232 | 42041189 |
| ENSE00003794915 | 42050557 | 42050601 |
Expression profiles
Bgee: expression breadth ubiquitous, 158 present calls, max score 83.21.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8760 / max 13.7506, expressed in 491 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166085 | 0.8760 | 491 |
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| kidney epithelium | UBERON:0004819 | 83.21 | gold quality |
| oviduct epithelium | UBERON:0004804 | 79.52 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 77.80 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 77.22 | gold quality |
| buccal mucosa cell | CL:0002336 | 77.15 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 76.22 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.46 | silver quality |
| myocardium | UBERON:0002349 | 72.68 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 72.53 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 71.91 | gold quality |
| upper arm skin | UBERON:0004263 | 71.54 | gold quality |
| biceps brachii | UBERON:0001507 | 69.28 | gold quality |
| quadriceps femoris | UBERON:0001377 | 69.15 | gold quality |
| vastus lateralis | UBERON:0001379 | 68.44 | gold quality |
| ventricular zone | UBERON:0003053 | 68.43 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 68.35 | gold quality |
| cerebellar cortex | UBERON:0002129 | 67.83 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 67.80 | gold quality |
| right uterine tube | UBERON:0001302 | 67.74 | gold quality |
| body of pancreas | UBERON:0001150 | 67.60 | gold quality |
| apex of heart | UBERON:0002098 | 67.47 | gold quality |
| pancreatic ductal cell | CL:0002079 | 67.41 | silver quality |
| cerebellum | UBERON:0002037 | 67.15 | gold quality |
| cerebellar vermis | UBERON:0004720 | 67.00 | gold quality |
| ganglionic eminence | UBERON:0004023 | 66.21 | gold quality |
| fallopian tube | UBERON:0003889 | 66.19 | gold quality |
| muscle tissue | UBERON:0002385 | 65.82 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 65.79 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 65.59 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 65.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.19 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zbtb8b | ENSDARG00000035889 |
Paralogs (5): ZBTB8A (ENSG00000160062), ZBTB10 (ENSG00000205189), ZBTB9 (ENSG00000213588), ZBTB22 (ENSG00000236104), ZBTB8B (ENSG00000273274)
Protein
Protein identifiers
Uncharacterized protein C17orf113 — A0A1B0GUU1 (reviewed: A0A1B0GUU1)
All UniProt accessions (1): A0A1B0GUU1
RefSeq proteins (1): NP_001345590* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR057456 | Znf_C17orf113 | Domain |
Pfam: PF25431
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GUU1-F1 | 82.18 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 2 (showing top):
PTPRA_TARGET_GENES, chr17q21
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
102 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C17orf113 | ANLN | Q9NQW6 | 166 |
| C17orf113 | ZC3H12A | Q5D1E8 | 166 |
| C17orf113 | KCNS3 | Q9BQ31 | 166 |
| C17orf113 | PDAP1 | Q13442 | 163 |
| C17orf113 | DSTN | P18282 | 163 |
| C17orf113 | TIMM17A | Q99595 | 163 |
| C17orf113 | LYPD6B | Q8NI32 | 158 |
| C17orf113 | SPON1 | Q9HCB6 | 155 |
| C17orf113 | C1QBP | Q07021 | 146 |
| C17orf113 | GTF2H4 | Q92759 | 141 |
| C17orf113 | INO80B | Q9C086 | 138 |
| C17orf113 | NSD1 | Q96L73 | 135 |
| C17orf113 | MRPL33 | O75394 | 129 |
| C17orf113 | UBE2S | Q16763 | 124 |
| C17orf113 | Q32Q12 | Q32Q12 | 122 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A061IR73, A0A1B0GUU1, A6H687, A8MYJ7, B1WC39, D3ZVB0, E1BD59, G3MY25, G3MZC5, O75064, P07199, P27790, P29597, P48988, P52333, P52824, Q08DF2, Q0VCE3, Q13608, Q1JPD6, Q2VPB7, Q3TAP4, Q3U1Y4, Q3ZBE0, Q499M4, Q53EQ6, Q5JZY3, Q62137, Q63272, Q6B0B8, Q6DI92, Q6ZPS2, Q6ZS72, Q7TM95, Q80VI1, Q86UT6, Q8BYG9, Q8N9M5, Q8R5G7, Q8TE96
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
4285 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:42043296:C:A | W27C | 1.000 |
| 17:42043296:C:G | W27C | 1.000 |
| 17:42043140:G:C | H79Q | 0.999 |
| 17:42043140:G:T | H79Q | 0.999 |
| 17:42043142:G:C | H79D | 0.999 |
| 17:42043142:G:T | H79N | 0.999 |
| 17:42043164:G:C | F71L | 0.999 |
| 17:42043164:G:T | F71L | 0.999 |
| 17:42043165:A:G | F71S | 0.999 |
| 17:42043166:A:G | F71L | 0.999 |
| 17:42043167:G:C | N70K | 0.999 |
| 17:42043167:G:T | N70K | 0.999 |
| 17:42043177:C:T | G67D | 0.999 |
| 17:42043185:G:C | F64L | 0.999 |
| 17:42043185:G:T | F64L | 0.999 |
| 17:42043187:A:G | F64L | 0.999 |
| 17:42043245:G:C | F44L | 0.999 |
| 17:42043245:G:T | F44L | 0.999 |
| 17:42043247:A:G | F44L | 0.999 |
| 17:42043249:A:G | M43T | 0.999 |
| 17:42043278:C:A | W33C | 0.999 |
| 17:42043278:C:G | W33C | 0.999 |
| 17:42043280:A:G | W33R | 0.999 |
| 17:42043280:A:T | W33R | 0.999 |
| 17:42043284:A:C | F31L | 0.999 |
| 17:42043284:A:T | F31L | 0.999 |
| 17:42043286:A:G | F31L | 0.999 |
| 17:42043297:C:G | W27S | 0.999 |
| 17:42043298:A:G | W27R | 0.999 |
| 17:42043298:A:T | W27R | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000074571 (17:42039517 G>A,C), RS1000420097 (17:42046801 C>G), RS1000479070 (17:42052520 T>A), RS1002424013 (17:42040818 C>T), RS1002675027 (17:42037876 G>A), RS1003428814 (17:42042348 C>T), RS1003502576 (17:42043920 G>A), RS1003607376 (17:42049320 A>G), RS1003774169 (17:42049929 T>C), RS1004103224 (17:42049804 C>T), RS1004401780 (17:42042266 A>C), RS1005737300 (17:42038857 G>A), RS1005788902 (17:42039076 C>A,T), RS1006341036 (17:42043775 C>G,T), RS1006452131 (17:42051990 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| Lipopolysaccharides | decreases expression, affects response to substance, increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.